Back

Artemisinin combined with low dose quinidine suppresses ventricular tachyarrhythmia in a model of Brugada syndrome

28 August 2023 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Treatment of life-threatening arrhythmias and cardiac arrest Drug Treatment of Ventricular Arrhythmias ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Hyung Ki Jeong

Wonkwang University Hospital, Iksan (Korea (Republic of))

8 More presentations in this session

Presentation thumbnail
Single beta-blocker or combined amiodarone therapy in ICD and CRT-D patients - Insights from the German DEVICE-registry
Doctor F. Wiedmann (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of percutaneous left stellate ganglion block in patients with refractory electrical storm: our five years experience.
Doctor S. Compagnoni (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Release velocity improvement with a new metronome-guided chest compression protocol: preliminary results of the RITMICO study
Ms G. Monachino (Viganello, CH)
Abstract Slides Video
Presentation thumbnail
Does the type of mechanical chest compressor affect resuscitation outcome of out of hospital cardiac arrest patients? A propensity-score based comparison of three devices.
Doctor S. Savastano (Pavia, IT)
Abstract Slides
Presentation thumbnail
An innovative MedIcaL dEcision Support tool for neurological ouTcome predictiOn from post-resuscitatioN Electrocardiograms (MILESTONE)
Doctor F. Gentile (Pavia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Treatment of life-threatening arrhythmias and cardiac arrest

The Event

Event poster

ESC Congress 2023

28 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparison of flavonoid effects in Brugada syndrome model
thumbnail
Congress Presentation
Why, when, and for whom should we use quinidine?
thumbnail
Congress Presentation
Monitoring the electrophysiological effects of hydroquinidine non-invasively in patients with Brugada syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources